Martell Bridget A 4
4 · Aligos Therapeutics, Inc. · Filed Feb 28, 2024
Insider Transaction Report
Form 4
Martell Bridget A
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-02-28+8,823→ 8,823 totalExercise: $0.96Exp: 2031-11-16→ Common Stock (8,823 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2024-02-27−30,000→ 0 totalExercise: $16.52From: 2021-12-16Exp: 2031-11-16→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]On February 27, 2024, the issuer canceled, pursuant to the issuer's option exchange program, an option for 30,000 of the issuer's shares granted to the reporting person on November 16, 2021. In exchange, on February 28, 2024, the reporting person received a replacement option, for 8,823 shares, having an exercise price of $0.96 per share.
- [F2]The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary.